ATORVASTATIN CALCIUM | A205519 | SCIEGEN PHARMACEUTICALS INC
Highest NADAC/Unit
$0.0700
per ea
Lowest NADAC/Unit
$0.0245
per ea
Brand NDCs
0
Generic NDCs
8
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 50228045405ATORVASTATIN 80 MG TABLET | $0.0700 | EA | Generic | — | 2026-06-17 |
| 50228045490ATORVASTATIN 80 MG TABLET | $0.0700 | EA | Generic | — | 2026-06-17 |
| 50228045310ATORVASTATIN 40 MG TABLET | $0.0379 | EA | Generic | — | 2026-06-17 |
| 50228045390ATORVASTATIN 40 MG TABLET | $0.0379 | EA | Generic | — | 2026-06-17 |
| 50228045205ATORVASTATIN 20 MG TABLET | $0.0285 | EA | Generic | — | 2026-06-17 |
| 50228045290ATORVASTATIN 20 MG TABLET | $0.0285 | EA | Generic | — | 2026-06-17 |
| 50228045110ATORVASTATIN 10 MG TABLET | $0.0245 | EA | Generic | — | 2026-06-17 |
| 50228045190ATORVASTATIN 10 MG TABLET | $0.0245 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.